Company Name:PTC Therapeutics, Inc.
CEO: Stuart W. Peltz

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.


Key numbers

Market Capitalization:2997005562
Shares Outstanding: 63725400
Float: 61509094
Next Earning Date:2020-08-05
TTm EPS: -4.9893
TTm Dividend Rate:
200 days moving average:48.37
50 days moving average: 51.19
One day percent Change: 2.89



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,